Neurocrine Biosciences
NBIX
#1309
Rank
HK$107.52 B
Marketcap
HK$1,062
Share price
2.74%
Change (1 day)
13.51%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$6.34 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are HK$6.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$7.96 B54.18%
2022-12-31HK$5.16 B-5.19%
2021-12-31HK$5.44 B15.46%
2020-12-31HK$4.71 B-9.48%
2019-12-31HK$5.21 B29.87%
2018-12-31HK$4.01 B15.29%
2017-12-31HK$3.48 B793.88%
2016-12-31HK$0.38 B-0.19%
2015-12-31HK$0.39 B46.48%
2014-12-31HK$0.26 B0.23%
2013-12-31HK$0.26 B-17.61%
2012-12-31HK$0.32 B-46.96%
2011-12-31HK$0.60 B-37.53%
2010-12-31HK$0.97 B87.75%
2009-12-31HK$0.51 B-17.59%
2008-12-31HK$0.62 B-48.92%
2007-12-31HK$1.23 B111.25%
2006-12-31HK$0.58 B-19.16%
2005-12-31HK$0.72 B-25.99%
2004-12-31HK$0.97 B-23.27%
2003-12-31HK$1.26 B285.1%
2002-12-31HK$0.32 B17.61%
2001-12-31HK$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$6.32 B-0.26%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$60.47 B 853.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$86.24 M-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$476.16 B 7,409.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.067 T 16,730.17%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$986.09 B 15,451.77%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.65 B 4.96%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.34 B-94.63%๐Ÿ‡บ๐Ÿ‡ธ USA